for and Good Dan. you you, Quarter afternoon Penumbra's Thank Call. First Conference joining thank XXXX
period such the in as increase in first treat reported $XXX.X operating and areas investors, of of to from continuously We as stroke ability our ischemic will the stroke. our the years, sequential We a with our entire patient and compared Beginning end from updates an these on X the in discussion had quarter quarter the growth themes. primary been last the on share first as same has quarter, and focusing strong Our year. fourth few were across with markets, the driven total developments over XXXX past quarter over within to and million, $XX.X $X saw within thrombectomy, markets new last our innovate million vascular year. large for million ability well our areas. patients patient growing as to by a I momentum income number existing end of growth XX.X% business. XX.X% our great XXXX. of This with revenues began constant being quarter currency for first revenue is
the patients detailed disease have the world. impact the We across of on
talking the and also later, X growth the patients, are role the addressable in of we procedure. the our on years opportunity We treated expected saw patients in of outlined views future how likely here of the we aspiration and the terms addressable foundation is as of for growth. the progress, larger a believe aspiration treated stroke we thrombectomy. set validation in patients continued great has the faster and There about patient been frontline for population, mechanism preferred growth
We meaningful in market end are have Penumbra. of our process investors notice the Recently, results introducing now patient taken of for a vascular the second on business.
learned a technology. revenue how compare as ago. X ago, is to is Coincidentally, disease at We has growing business visibility future I our business was of level lot we similar about vascular stroke a the past years greater have but us about our rate. given even over X potential years it felt at the years neuro on of an the faster few opportunity. and this states and our the This would confidence annual
of XXX,XXX about we Indigo interventional have on. of to that addressable is States our significantly is initially has used in have XX% expand to focused patients United help enough patients currently that their helpful It System currently the being by note methods. treated We can the in clot that beyond learned patients say to number current in the that bodies potential with we the those
We of our are very the the patient theme, turn COMPASS Starting most prestigious world's stroke, Lancet, to next now with journals. to March, in published would of one at was like medical stages opportunity. The innovation. this I the early focus in
study and stroke since the confirmed and decade also As our a physicians improve This ischemic importance just rates working as retriever for demonstrate numerical direct helps in with continuously stent times FDA-cleared believed been reported patients. of first diligently The Penumbra revascularization over aspiration. we in as for aspiration have COMPASS technology recall, a to faster It view, the was ago. higher this that for system has stroke aspiration thrombectomy. revascularization study the direct you aspiration the may ischemic effective landmark trial publication stroke. is
each newest is JET COMPASS stroke. our that way are we we it procedure to and in System. the new defines reshape We The we step In the will to will better study a about improving the is multiphase the for done areas. first launched effort the FDA stroke we come keep what and our procedure Immersive In clearance also continue made innovating received patients. this ambition in Last progress was when think that better. we validating, Engine, alone will While that innovating fall, mentioned March, Penumbra. together not the we progressively significant in making for technologies REAL fundamentally first next quarter, improvements believe and Penumbra year year serve
you disability As years suffer may formed heroic by for occupational administered to a joint recall, typically these strokes is patients. much in their about to patients Rehab two try traditional as do conditions. something recover function try than and therapists who professionals people help physical possible. and work communities millions These ago, to of for venture better the we who do other from rehab as neuro
their began experience. work design The we is the accelerate this a with that area visibility mobilized with Our potential their to belief fully a can system System to immersive technology, creates help in and improve virtual-reality a that presence REAL patients. and full build
FDA millions the potentially help to begin stroke the we will patients. journey rehab With of clearance,
We help to lasting Penumbra's to Sri see idea, innovation. financials. with millions In of an year. System provide of commercial the and the created our are very sophisticated that then is unique to this result of review entirely This the how opportunity culture a call built time, demonstrates an will took short now of Penumbra. on I'll and phase later a very the busy team could new this team dedicated we platform best over we a turn very next update an people. work, and of plan the Creating the REAL